Tumor ablation using novel photothermal Na_xWO₃ nanoparticles against breast cancer osteolytic bone metastasis

References

• Lin Z, Liu Y, Ma X, et al. Photothermal ablation of bone metastasis of breast cancer using PEGylated multi-walled carbon nanotubes. Sci Rep. 2015;5:11709. doi:10.1038/srep1170926122018
   PubMedGoogle Scholar
• Fan L, Strasser-Weippl K, Li J-J, et al. Breast cancer in China. Lancet Oncol. 2014;15(7):e279–e289. doi:10.1016/S1470-2045(13)70567-924872111
   PubMed Web of Science ®Google Scholar
• Croset M, Goehrig D, Frackowiak A, et al. TWIST1 expression in breast cancer cells facilitates bone metastasis formation. J Bone Miner Res. 2014;29(8):1886–1899. doi:10.1002/jbmr.221524619707
   PubMedGoogle Scholar
• Yuan G, Lian Z, Liu Q, et al. Phosphatidyl inositol 3-kinase (PI3K)-mTOR inhibitor PKI-402 inhibits breast cancer induced osteolysis. Cancer Lett. 2019;443:135–144. doi:10.1016/j.canlet.2018.11.03830540926
   PubMed Web of Science ®Google Scholar
• Steenbruggen TG, van Ramshorst MS, Kok M, Linn SC, Smorenburg CH, Sonke GS. Neoadjuvant therapy for breast cancer: established concepts and emerging strategies. Drugs. 2017;77(12):1313–1336. doi:10.1007/s40265-017-0774-528616845
   PubMedGoogle Scholar
• Woo SB, Solomon DH. Bisphosphonate therapy for cancer and prevalence of inflammatory jaw conditions. J Natl Cancer Inst. 2007;99(13):986–987. doi:10.1093/jnci/djm02917596571
   PubMedGoogle Scholar
• Josse R, Khan A, Ngui D, Shapiro M. Denosumab, a new pharmacotherapy option for postmenopausal osteoporosis. Curr Med Res Opin. 2013;29(3):205–216. doi:10.1185/03007995.2013.76377923297819
   PubMed Web of Science ®Google Scholar
• Jiang M, Yan Y, Yang K, et al. Small molecule nAS-E targeting cAMP response element binding protein (CREB) and CREB-binding protein interaction inhibits breast cancer bone metastasis. J Cell Mol Med. 2019;23(2):1224–1234. doi:10.1111/jcmm.1402430461194
   PubMedGoogle Scholar
• Eyvazzadeh N, Shakeri-Zadeh A, Fekrazad R, Amini E, Ghaznavi H, Kamran Kamrava S. Gold-coated magnetic nanoparticle as a nanotheranostic agent for magnetic resonance imaging and photothermal therapy of cancer. Lasers Med Sci. 2017;32(7):1469–1477. doi:10.1007/s10103-017-2267-x28674789
   PubMed Web of Science ®Google Scholar
• Mirrahimi M, Abed Z, Beik J, et al. A thermo-responsive alginate nanogel platform co-loaded with gold nanoparticles and cisplatin for combined cancer chemo-photothermal therapy. Pharmacol Res. 2019;143:178–185. doi:10.1016/j.phrs.2019.01.00530611856
   PubMed Web of Science ®Google Scholar
• Hauck TS, Jennings TL, Yatsenko T, Kumaradas JC, Chan WCW. Enhancing the toxicity of cancer chemotherapeutics with gold nanorod hyperthermia. Adv Mater. 2010;20(20):3832–3838. doi:10.1002/adma.v20:20
   Web of Science ®Google Scholar
• Dong K, Liu Z, Li Z, Ren J, Qu X. Hydrophobic anticancer drug delivery by a 980 nm laser-driven photothermal vehicle for efficient synergistic therapy of cancer cells in vivo. Adv Mater. 2013;25(32):4452–4458. doi:10.1002/adma.20130123223798450
   PubMed Web of Science ®Google Scholar
• Huang P, Lin J, Li W, et al. Biodegradable gold nanovesicles with an ultrastrong plasmonic coupling effect for photoacoustic imaging and photothermal therapy. Angew Chem Int Ed. 2013;125(52):13958–13964. doi:10.1002/anie.201308986
   Google Scholar
• Lal S, Clare SE, Halas NJ. Nanoshell-enabled photothermal cancer therapy: impending clinical impact. Acc Chem Res. 2008;41(12):1842–1851. doi:10.1021/ar800150g19053240
   PubMed Web of Science ®Google Scholar
• O’Neal DP, Hirsch LR, Halas NJ, Payne JD, West JL. Photo-thermal tumor ablation in mice using near infrared-absorbing nanoparticles. Cancer Lett. 2004;209(2):171–176. doi:10.1016/j.canlet.2004.02.00415159019
   PubMed Web of Science ®Google Scholar
• Huang X, El-Sayed IH, Qian W, El-Sayed MA. Cancer cell imaging and photothermal therapy in the near-infrared region by using gold nanorods. J Am Chem Soc. 2006;128(6):2115–2120. doi:10.1021/ja057254a16464114
   PubMed Web of Science ®Google Scholar
• Alamzadeh Z, Beik J, Pirhajati Mahabadi V, et al. Ultrastructural and optical characteristics of cancer cells treated by a nanotechnology based chemo-photothermal therapy method. J Photochem Photobiol B. 2019;192:19. doi:10.1016/j.jphotobiol.2019.01.00530665146
   PubMed Web of Science ®Google Scholar
• Beik J, Khademi S, Attaran N, et al. A nanotechnology based strategy to increase the efficiency of cancer diagnosis and therapy: folate conjugated gold nanoparticles. Curr Med Chem. 2017;24(39):4399–4416.28799495
   PubMed Web of Science ®Google Scholar
• Beik J, Khateri M, Khosravi Z, et al. Gold nanoparticles in combinatorial cancer therapy strategies. Coord Chem Rev. 2019;387:299–324. doi:10.1016/j.ccr.2019.02.025
   Web of Science ®Google Scholar
• Ghaznavi H, Hosseini-Nami S, Kamrava SK, et al. Folic acid conjugated PEG coated gold–iron oxide core–shell nanocomplex as a potential agent for targeted photothermal therapy of cancer. Artif Cells Nanomed Biotechnol. 2017;46(8):1–11. doi:10.1080/21691401.2017.1384384
   Web of Science ®Google Scholar
• Mirrahimi M, Hosseini V, Kamrava SK, et al. Selective heat generation in cancer cells using a combination of 808 nm laser irradiation and the folate-conjugated Fe2O3@Au nanocomplex. Artif Cell. 2018;46(sup1):241–253.
   Google Scholar
• Liu T, Wang C, Gu X, et al. Drug delivery with PEGylated MoS_2 nano-sheets for combined photothermal and chemotherapy of cancer. Adv Mater. 2014;26(21):3433–3440. doi:10.1002/adma.20130525624677423
   PubMed Web of Science ®Google Scholar
• Song XR, Wang X, Yu S-X, et al. Co9Se8 nanoplates as a new theranostic platform for photoacoustic/magnetic resonance Dual‐Modal‐Imaging‐Guided Chemo‐Photothermal combination therapy. Adv Mater. 2015;27(21):3285–3291. doi:10.1002/adma.20140563425885638
   PubMedGoogle Scholar
• Yong Y, Cheng X, Bao T, et al. Tungsten sulfide quantum dots as multifunctional nanotheranostics for in vivo dual-modal image-guided photothermal/radiotherapy synergistic therapy. ACS Nano. 2015;9(12):12451–12463. doi:10.1021/acsnano.5b0582526495962
   PubMed Web of Science ®Google Scholar
• Liu Z, Chen K, Davis C, et al. Drug delivery with carbon nanotubes for in vivo cancer treatment. Cancer Res. 2008;68(16):6652. doi:10.1158/0008-5472.CAN-07-587318701489
   PubMed Web of Science ®Google Scholar
• Yang K, Zhang S, Zhang G, et al. Graphene in mice: ultrahigh in vivo tumor uptake and efficient photothermal therapy. Nano Lett. 2010;10(9):3318. doi:10.1021/nl101715720684528
   PubMed Web of Science ®Google Scholar
• Cong S, Yuan Y, Chen Z, et al. Noble metal-comparable SERS enhancement from semiconducting metal oxides by making oxygen vacancies. Nat Commun. 2015;6(6, 7):7800. doi:10.1038/ncomms880026183467
   PubMedGoogle Scholar
• Gordon TR, Cargnello M, Paik T, et al. Nonaqueous synthesis of TiO2 nanocrystals using TiF4 to engineer morphology, oxygen vacancy concentration, and photocatalytic activity. J Am Chem Soc. 2012;134(15):6751–6761. doi:10.1021/ja300823a22444667
   PubMedGoogle Scholar
• Xi G, Ouyang S, Li P, et al. Ultrathin W 18 O 49 nanowires with diameters below 1 nm: synthesis, near-infrared absorption, photoluminescence, and photochemical reduction of carbon dioxide. Angew Chem Int Ed. 2012;51(10):2395–2399. doi:10.1002/anie.201107681
   PubMed Web of Science ®Google Scholar
• Huang Q, Hu S, Zhuang J, Wang X. MoO3–x‐based hybrids with tunable localized surface plasmon resonances: chemical oxidation driving transformation from ultrathin nanosheets to nanotubes. Chemistry. 2012;18(48):15283–15287. doi:10.1002/chem.20120263023129418
   PubMedGoogle Scholar
• Ouyang Z, Wang S, Zeng M, et al. Therapeutic effect of palbociclib in chondrosarcoma: implication of cyclin-dependent kinase 4 as a potential target. Cell Commun Signal. 2019;17(1):17. doi:10.1186/s12964-019-0327-530808351
   PubMedGoogle Scholar
• Ouyang Z, Guo X, Chen X, et al. Hypericin targets osteoclast and prevents breast cancer-induced bone metastasis via NFATc1 signaling pathway. Oncotarget. 2018;9(2):1868–1884. doi:10.18632/oncotarget.2293029416737
   PubMedGoogle Scholar
• Zhu W, Yin Z, Zhang Q, et al. Proanthocyanidins inhibit osteoclast formation and function by inhibiting the NF-kappaB and JNK signaling pathways during osteoporosis treatment. Biochem Biophys Res Commun. 2019;509(1):294–300. doi:10.1016/j.bbrc.2018.12.12530583865
   PubMedGoogle Scholar
• Ouyang Z, Tan T, Liu C, et al. Targeted delivery of hesperetin to cartilage attenuates osteoarthritis by bimodal imaging with Gd2(CO3)3@PDA nanoparticles via TLR-2/NF-κB/Akt signaling. Biomaterials. 2019;205:50–63. doi:10.1016/j.biomaterials.2019.03.01830903825
   PubMed Web of Science ®Google Scholar
• Zhang Q, Tang X, Liu Z, et al. Hesperetin prevents bone resorption by inhibiting RANKL-induced osteoclastogenesis and Jnk mediated Irf-3/c-Jun activation. Front Pharmacol. 2018;9:1028. doi:10.3389/fphar.2018.0102830254586
   PubMed Web of Science ®Google Scholar
• Ouyang Z, Huang Q, Liu B, et al. Rubidium chloride targets Jnk/p38-mediated NF-kappaB activation to attenuate osteoclastogenesis and facilitate osteoblastogenesis. Front Pharmacol. 2019;10:584. doi:10.3389/fphar.2019.0084831191317
   PubMed Web of Science ®Google Scholar